🟢 Lipocine is trading 8% up today as softer rate-hike expectations support equities

Lipocine is trading at $2.22, up 7.95% on August 13, 2026, as broader risk appetite supports equities after softer rate-hike expectations following CPI.

• The S&P 500, Nasdaq Composite, and Dow Jones are up 0.67%, 0.90%, and 0.30%, respectively.
• No fresh company-specific announcement was identified; the latest listed releases are the August 4 quarterly results and August 3 board appointment.
• Earlier clinical-trial and earnings news is stale and does not directly explain the August 13 move.